Thomas Steyer’s SpringWorks Therapeutics SWTX Stock Holding History

Thomas Steyer’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,000	Closed	-$235K	–	160
2025 Q2	$235K	Sell	5,000 -113,000	-96%	-$5.03M	﹤0.01%	116
2025 Q1	$5.21M	Buy	+118,000	New	+$5.43M	0.03%	80
2024 Q2	–	Sell	-5,000	Closed	-$246K	–	183
2024 Q1	$246K	Buy	+5,000	New	+$231K	﹤0.01%	136

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Thomas Steyer's SWTX Position: Q3 2025 in Review

Thomas Steyer sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 5,000 shares — an estimated $235K sold.

Thomas Steyer first reported a position in SWTX in Q1 2024 and held it in 3 quarters. The position peaked at $5.21M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Thomas Steyer reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Thomas Steyer sold 5,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $235K.
Thomas Steyer first reported a position in SpringWorks Therapeutics in Q1 2024 and held it in 3 quarters.
Thomas Steyer's SpringWorks Therapeutics position peaked at $5.21M in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Farallon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.